Mufaddal Mahesri

Record: found Abstract: found Article: not found Author(s): Publication date: ScienceOpenPublisherPubMed There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience. We evaluated whether drugs approved for other indications that also target metabolic drivers of Alzheimer's disease and related dementia (ADRD) pathogenesis are associated with delayed onset of ADRD.

CONFLICT OF INTEREST Dr. Desai reports serving as Principal Investigator on research grants from Bayer, Vertex, and Novartis to the Brigham & Women's Hospital for unrelated projects. Dr. Gerhard reports grants from NIA during the conduct of the study; grants and personal fees from Bristol-Myers Sqibb; personal fees from Merck, Pfizer, Lilly, IntraCellular Therapies, and Eisai. All outside the submitted work.

Back to Journals » Clinical Epidemiology » Volume 17 Authors Wang KY, Mahesri M , Novoa-Laurentiev J, Bessette LG , York C , Zakoul H, Lee SB, Ngan K, Zhou L, Kim DH , Lin KJ Received 19 November 2024 Accepted for publication 26 March 2025 Published 15 April 2025 Volume 2025:17 Pages 353—365 DOI https://doi.org/10.2147/CLEP.S504259 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Henrik Sørensen Kuan-Yuan...